Literature DB >> 8382837

The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat.

R Fabia1, A Ar'Rajab, M L Johansson, R Willén, R Andersson, G Molin, S Bengmark.   

Abstract

The potential beneficial effect of exogenous administration of Lactobacillus on acetic acid-induced colitis was evaluated in the rat. Colitis was induced by instillation of 4% acetic acid for 15 sec in an exteriorized colonic segment. This produced uniform colitis with a threefold increase in myeloperoxidase (MPO) activity of the colonic tissue (an index of neutrophil infiltration) and a sixfold increase in plasma exudation into the lumen of the colon (mucosal permeability) as evaluated 4 days after acetic acid administration. Intracolonic administration of L. reuteri R2LC immediately after acetic acid administration, at a dose of 5 ml of 7 x 10(7) colony-forming units (CFU)/ml in two forms: either as pure bacterial suspension or as fermented oatmeal soup, prevented the development of colitis. Thus, the morphologic score, MPO activity, and mucosal permeability were almost normalized by Lactobacillus treatment. Initiating the treatment 24 h after acetic acid administration or using lower doses of 1 ml for 3 consecutive days resulted in a smaller protective effect. We conclude that exogenous administration of L. reuteri R2LC prevents the development of acetic acid-induced colitis in the rat.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382837     DOI: 10.3109/00365529309096063

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  31 in total

Review 1.  Bacteria as the cause of ulcerative colitis.

Authors:  M Campieri; P Gionchetti
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

Review 2.  Probiotics and inflammatory bowel disease.

Authors:  Daisy Jonkers; Reinhold Stockbrügger
Journal:  J R Soc Med       Date:  2003-04       Impact factor: 5.344

Review 3.  Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm.

Authors:  Jens Walter; Robert A Britton; Stefan Roos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-25       Impact factor: 11.205

Review 4.  Probiotics and barrier function in colitis.

Authors:  P Gionchetti; K M Lammers; F Rizzello; M Campieri
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 5.  Probiotics and inflammatory bowel diseases.

Authors:  A-P Bai; Q Ouyang
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

Review 6.  Antibiotics and probiotics in treatment of inflammatory bowel disease.

Authors:  Paolo Gionchetti; Fernando Rizzello; Karen-M Lammers; Claudia Morselli; Lucia Sollazzi; Samuel Davies; Rosy Tambasco; Carlo Calabrese; Massimo Campieri
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 7.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

8.  Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.

Authors:  T Mimura; F Rizzello; U Helwig; G Poggioli; S Schreiber; I C Talbot; R J Nicholls; P Gionchetti; M Campieri; M A Kamm
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats.

Authors:  György Rumi; Ryouichi Tsubouchi; Mitsuaki Okayama; Shinichi Kato; Gyula Mózsik; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

10.  Therapeutic effects of four strains of probiotics on experimental colitis in mice.

Authors:  Lin Lin Chen; Xue Hong Wang; Yi Cui; Guang Hui Lian; Jie Zhang; Chun Hui Ouyang; Fang Gen Lu
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.